Prof. Thierry Facon

 

 

Thierry FACON, MD

Lille University Hospital, Lille, France and French Academy of Medicine, Paris, France. Thierry Facon, MD, is Professor of Haematology in the Department of Haematology, Lille University Hospital, Lille, France, a position he has held since 2000. He is a Member of the French National Academy of Medicine, and General Secretary of the Foundation of the French National Academy of Medicine. He currently serves as a member of the Transparency Committee of the French National Authority for Health.

Professor Facon was President of the French Society of Hematology between 2021 and 2024 and President of the Intergroupe Francophone du Myélome (IFM) between 2003 and 2006. He has presented at several international congresses, including the Plenary session at the annual meeting of the American Society of Clinical Oncology (ASCO) in 2006, the Plenary sessions at the annual meeting of the American Society of Hematology (ASH) in 2013 and 2018, the Plenary Session at the annual meeting of the European Haematology Association (EHA) in 2024. He also presented at the Educational sessions of EHA 2008 and 2014, and the Educational sessions of ASH in 2015 and 2018. He co-organized the XIIIth International He is an Honorary Professor at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, China since 2015 Myeloma Workshop (IMW) in Paris in 2011, and is a member of the American Society of Hematology (ASH), the European Haematology Association (EHA), the International Myeloma Working Group (IMWG), and the International Myeloma Society (IMS). He serves currently as Associate Editor of Leukemia, and is a founder member and administrator of the Fondation Française pour la Recherche contre le Myélome et les Gammapathies (FFRMG) under the aegis of the Fondation de France whose main objective is to enable scientists and
students to carry out research programs in host laboratories in France or abroad. He is a co-organizer of the myeloma international COMY meeting.

He has presented the “Pierre Stryckmans Memorial Lecture” of the Belgian Hematological Society in 2015. He received the Joseph Michaeli Award from Weill Cornell Medicine, New York, USA, for his contributions to the treatment of Myeloma Research, and the Saint Antoine EBMT achievement Award in 2017. He received the Robert Kyle career achievement Award in 2020 and the Waldenstrom Life Time Achievement Award from the International Myeloma Society in 2024. He is an Honorary Professor at the Institute of Hematology &
Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, China since 2015. Professor Facon is author and co-author of a number of articles and has published his work in various prestigious international journals including, as first or senior author, The Lancet, Nature Medicine, and The New England Journal of Medicine.